CASI Pharmaceuticals, Inc.

Casi Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics in the treatment of various types of cancer. The company's primary aim is to address the unmet clinical needs within the oncology sector, bringing advanced and effective treatment options to patients globally. Casi Pharmaceuticals Inc. leverages its strategic partnerships and distribution networks primarily across the North American and Asian markets, facilitating the development and delivery of their therapies. The company engages in late-stage clinical trials and regulatory approvals, with a focus on expanding its product pipeline through both in-house developments and strategic acquisitions. With a commitment to enhancing therapeutic efficacy and patient outcomes, Casi Pharmaceuticals Inc. plays a significant role in pioneering cancer treatment solutions, contributing to advancements in the healthcare and life sciences industries.